Data Integrity and Form 483 or Warning Letters
April 28, 2014 / /
Posted in FDA Enforcement, FDA News Update and tagged with 21 CFR, 483, 58, BIMO, Bioresearch, CBER, CDER, clinical, compliance, CPGM, data, FORM, GUIDANCE, integrity, LETTER, manual, Monitoring, non, OBSERVATIONS, Part, pre, PROGRAM, research, studies, STUDY, Subpart, WARNING
Are you in trouble with the FDA?
Don’t panic — you’ve got backup. Download 5 Tips to Help You Navigate FDA Enforcement and learn how to resolve the situation right now.
Leave a Comment
You must be logged in to post a comment.